(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 1g

2-Chloro-4-fluoronicotinic acid, 95.0%, 250mg

N-(2,4-dimethoxybenzyl)-2-oxo-N-(thiazol-2-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 95%, 250mg

Ethyl 4-pyrimidinecarboxylate, 95.0%, 25g

2-Chloro-N-(2-indol-3-ylethyl)propanamide, 95%, 2g

(2-Bromophenylethynyl)trimethylsilane, 98%, 5g

Espátula ROTILABO®, 420 mm, 2 Pieza(s)

METHYL 2,4-DIHYDROXYPHENYLACETATE, 97.0%, 250mg

2,5-Bis(2-ethylhexyl)-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95%, 10g

3-Ethoxycarbonylphenylboronic acid, 97.0%, 10g

Film transparente, 1 pieza

[1-(Pyridin-3-ylmethyl)piperidin-4-yl]methanamine trihydrochloride, 95.0%, 1g

4-Bromo-6-chloropyridin-3-amine, 98%, 250mg